Hitoshi Maegawa

743 total citations
26 papers, 664 citations indexed

About

Hitoshi Maegawa is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Hitoshi Maegawa has authored 26 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Hitoshi Maegawa's work include Drug Transport and Resistance Mechanisms (9 papers), Ion channel regulation and function (5 papers) and Anesthesia and Pain Management (4 papers). Hitoshi Maegawa is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Ion channel regulation and function (5 papers) and Anesthesia and Pain Management (4 papers). Hitoshi Maegawa collaborates with scholars based in Japan, United States and Germany. Hitoshi Maegawa's co-authors include Ken‐ichi Inui, R Hori, Tetsuya Okano, Mikihisa Takano, Nobuo Katsube, M Takano, Ryusuke Hori, Katsuhiko Nakai, Christoph Peters and Tomonobu Okano and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Hitoshi Maegawa

26 papers receiving 649 citations

Peers

Hitoshi Maegawa
Ellen Y. Wu United States
Young‐Sook Kang South Korea
Scott M. Ocheltree United States
C. Delbart France
Hitoshi Maegawa
Citations per year, relative to Hitoshi Maegawa Hitoshi Maegawa (= 1×) peers Kimio Tohyama

Countries citing papers authored by Hitoshi Maegawa

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Maegawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Maegawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Maegawa more than expected).

Fields of papers citing papers by Hitoshi Maegawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Maegawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Maegawa. The network helps show where Hitoshi Maegawa may publish in the future.

Co-authorship network of co-authors of Hitoshi Maegawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Maegawa. A scholar is included among the top collaborators of Hitoshi Maegawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Maegawa. Hitoshi Maegawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Wenhao, et al.. (2012). Inhibition of the activation of hepatic stellate cells by arundic acid via the induction of cytoglobin. Biochemical and Biophysical Research Communications. 425(3). 642–648. 16 indexed citations
2.
Ishikado, Atsushi, Yoshihiko Nishio, Katsutaro Morino, et al.. (2009). Abstract: P660 SOY PHOSPHATIDYLCHOLINE INHIBITED TLR4-MEDIATED MCP-1 EXPRESSION IN CULTURED VASCULAR CELLS. Atherosclerosis Supplements. 10(2). e846–e846. 1 indexed citations
4.
Seko, Takuya, Masashi Kato, Hiroshi Kohno, et al.. (2003). Structure–activity study of l-amino acid-based N-type calcium channel blockers. Bioorganic & Medicinal Chemistry. 11(8). 1901–1913. 8 indexed citations
5.
Nakai, Katsuhiko, et al.. (2003). Effects of OP-1206 α-CD on walking dysfunction in the rat neuropathic intermittent claudication model: comparison with nifedipine, ticlopidine and cilostazol. Prostaglandins & Other Lipid Mediators. 71(3-4). 253–263. 8 indexed citations
6.
Nakai, Katsuhiko, et al.. (2003). Effects of orally administered OP-1206 α-CD with loxoprofen-Na on walking dysfunction in the rat neuropathic intermittent claudication model. Prostaglandins Leukotrienes and Essential Fatty Acids. 69(4). 269–273. 7 indexed citations
7.
Nakai, Katsuhiko, et al.. (2002). The Effects of OP-1206 α-CD on Walking Dysfunction in the Rat Neuropathic Intermittent Claudication Model. Anesthesia & Analgesia. 94(6). 1537–1541. 18 indexed citations
8.
Seko, Takuya, Masashi Kato, Hiroshi Kohno, et al.. (2002). l-Cysteine based N-type calcium channel blockers: structure–activity relationships of the C-terminal lipophilic moiety, and oral analgesic efficacy in rat pain models. Bioorganic & Medicinal Chemistry Letters. 12(17). 2267–2269. 17 indexed citations
9.
Nishioku, Tsuyoshi, Kouichi Hashimoto, Keizo Yamashita, et al.. (2002). Involvement of Cathepsin E in Exogenous Antigen Processing in Primary Cultured Murine Microglia. Journal of Biological Chemistry. 277(7). 4816–4822. 84 indexed citations
10.
Nakai, Katsuhiko, et al.. (2002). The Effects of OP-1206 α-CD on Walking Dysfunction in the Rat Neuropathic Intermittent Claudication Model. Anesthesia & Analgesia. 94(6). 1537–1541. 11 indexed citations
11.
Seko, Takuya, Masashi Kato, Hiroshi Kohno, et al.. (2002). Structure–Activity Study of l-Cysteine-Based N-Type Calcium Channel Blockers: Optimization of N- and C-Terminal Substituents. Bioorganic & Medicinal Chemistry Letters. 12(6). 915–918. 13 indexed citations
12.
Seko, Takuya, Masashi Kato, Hiroshi Kohno, et al.. (2001). Structure–Activity Study and Analgesic Efficacy of Amino Acid Derivatives as N-Type Calcium Channel Blockers. Bioorganic & Medicinal Chemistry Letters. 11(16). 2067–2070. 15 indexed citations
13.
Maegawa, Hitoshi, et al.. (1992). Arginine-vasopressin fragment 4–9 stimulates the acetylcholine release in hippocampus of freely-moving rats. Life Sciences. 51(4). 285–293. 28 indexed citations
14.
Maegawa, Hitoshi, et al.. (1989). Effect of various chemical modifiers on H+ coupled transport of cephradine via dipeptide carriers in rabbit intestinal brush-border membranes: role of histidine residues.. Journal of Pharmacology and Experimental Therapeutics. 251(2). 745–749. 30 indexed citations
15.
Inui, Ken-ichi, Mikihisa Takano, Hitoshi Maegawa, Miyako Kato, & Ryohei Hori. (1989). Decreased Transport of p-Aminohippurate in Renal Basolateral Membranes Isolated from Rats with Acute Renal Failure. Pharmaceutical Research. 6(11). 954–957. 8 indexed citations
16.
Hori, R, et al.. (1989). Inhibitory Effect of Diethyl Pyrocarbonate on the H+/Organic Cation Antiport System in Rat Renal Brush-border Membranes. Journal of Biological Chemistry. 264(21). 12232–12237. 25 indexed citations
17.
Inui, Ken‐ichi, et al.. (1988). H+ coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine.. Journal of Pharmacology and Experimental Therapeutics. 247(1). 235–241. 81 indexed citations
18.
Maegawa, Hitoshi, et al.. (1987). TRANSPORT MECHANISMS OF β-LACTAM ANTIBIOTICS IN INTESTINAL BRUSH-BORDER MEMBRANES. Journal of Pharmacobio-Dynamics. 10(5). 4 indexed citations
19.
Saito, Hideyuki, Ken‐ichi Inui, Yasuhisa Matsukawa, et al.. (1986). Specific binding of atrial natriuretic polypeptide to renal basolateral membranes in spontaneously hypertensive rats (SHR) and stroke-prone SHR. Biochemical and Biophysical Research Communications. 137(3). 1079–1085. 20 indexed citations
20.
Okano, Tetsuya, Ken‐ichi Inui, Hitoshi Maegawa, Mikihisa Takano, & R Hori. (1986). H+ coupled uphill transport of aminocephalosporins via the dipeptide transport system in rabbit intestinal brush-border membranes.. Journal of Biological Chemistry. 261(30). 14130–14134. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026